TFG Asset Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Other funds holding CUE
TFG Asset Management's CUE Position: Q3 2026 in Review
TFG Asset Management sold out of Cue Biopharma (CUE) in Q3 2026, closing a stake of 93,819 shares — an estimated $2.96M sold.
TFG Asset Management first reported a position in CUE in Q2 2026 and held it in 1 quarter. The position peaked at $2.96M in Q2 2026. 58 funds tracked by Wall St. Rank hold CUE as of Q3 2026.
- TFG Asset Management reported no remaining Cue Biopharma position as of Q3 2026 after selling out during the quarter.
- TFG Asset Management sold 93,819 Cue Biopharma shares in Q3 2026, an estimated $2.96M.
- TFG Asset Management first reported a position in Cue Biopharma in Q2 2026 and held it in 1 quarter.
- TFG Asset Management's Cue Biopharma position peaked at $2.96M in Q2 2026.
- 58 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.
Based on TFG Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.